Clinical trial

Differential Immune Effects of Natalizumab

NCT00859482

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2006-07-01

PhaseN/A

Study timeline

Study start (unknown)2006-07-01Date precision: month

Registry last updated2009-03-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosis, Relapsing Remittingunresolved

Interventions

Sponsors & collaborators

Cantonal Hospital of St. Gallenlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00859482 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.